US Patent Issued to GigaMune on Dec. 16 for "Engineered cells expressing anti-viral T cell receptors and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,711, issued on Dec. 16, was assigned to GigaMune Inc. (San Francisco).

"Engineered cells expressing anti-viral T cell receptors and methods of use thereof" was invented by Matthew James Spindler (San Francisco), David Scott Johnson (San Francisco), Ayla Lynn Nelson (San Francisco), Ellen Kathleen Wagner (San Mateo, Calif.), Adam Shultz Adler (Belmont, Calif.), Yoong Wearn Lim (South San Francisco, Calif.) and Michael Asensio (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising recombinant mammalian cells that express recombinant T cell rectors with specificity against EBV or CMV pept...